4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000211
EVP, Chf Clinical Develop Ofcr sold 19,658 shares at an average $60.81 ($1,195,421)
- EVP, Chf Clinical Develop Ofcr acquired 19,658 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Schneider Eugene · EVP, Chf Clinical Develop Ofcr
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-09-03 | Exercise or conversion : show line 1 in the form 10b5-1 | +19,658 | $53.77 | $1,057,011 | 71,165 | D |
| 2025-09-03 | Sale : show line 2 in the form 10b5-1 | −12,455 | $60.46 | $753,039 | 58,710 | D |
| 2025-09-03 | Sale : show line 3 in the form 10b5-1 | −7,203 | $61.42 | $442,382 | 51,507 | D |
| Open-market sales · 19,658 sh · avg $60.81 · $1,195,421 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-09-03 | Exercise or conversion : show line 4 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −19,658 | 0 | D |
Loading xslF345X05/edgardoc.xml…